Seven Eight Capital, LP Twist Bioscience Corp Transaction History

Seven Eight Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$15.08 - $38.61 $351,439 - $899,806	23,305 Added 154.18%	38,420 $1.42 Million
Q3 2023 Nov 14, 2023	BUY	$18.62 - $26.57 $281,441 - $401,605	15,115 New	15,115 $306,000
Q1 2023 May 12, 2023	BUY	$14.6 - $30.9 $1.12 Million - $2.37 Million	76,726 New	76,726 $1.16 Million
Q3 2022 Nov 10, 2022	BUY	$33.44 - $56.56 $386,198 - $653,211	11,549 New	11,549 $407,000
Q4 2021 Feb 14, 2022	SELL	$75.47 - $135.88 $348,595 - $627,629	-4,619 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$95.64 - $131.48 $392,124 - $539,068	-4,100 Reduced 47.02%	4,619 $494,000
Q2 2021 Aug 13, 2021	BUY	$88.13 - $142.06 $768,405 - $1.24 Million	8,719 New	8,719 $1.16 Million

256

66.8M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.38B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.